Description: G.ST Antivirals is a Vienna-based Spin-Off from the Medical University of Vienna. It is dedicated to the development of therapies against different viruses applying an entirely novel approach of antiviral therapy.
Going after the viral achilles' heel G.ST Antivirals is a clinical-stage biotech company that applies an innovative host cell-based strategy to develop broad-spectrum antivirals against infections of the respiratory tract.
Treatments against the vast majority of viruses are scarce, and often leave physicians empty handed when dealing with viral infections.
G.ST Antivirals is determined to apply its innovative host cell-based strategy to develop broad-spectrum antivirals against infections of the respiratory tract such as the common cold.